Baseman Joel B, Cagle Marianna, Korte Jeffrey E, Herrera Caleb, Rasmussen Wanda G, Baseman Janet G, Shain Rochelle, Piper Jeanna M
Department of Microbiology and Immunology, University of Texas Health Science Center, San Antonio, Texas 78229-3900, USA.
J Clin Microbiol. 2004 Jan;42(1):203-11. doi: 10.1128/JCM.42.1.203-211.2004.
Detection of Mycoplasma genitalium-mediated, chlamydia-negative nongonococcal urethritis and other M. genitalium-linked infectious etiologies has been very challenging. Although M. genitalium is considered a leading cause of genitourinary symptoms in men and women, extreme difficulties in its cultivation due to its highly fastidious nature and the lack of routine and effective diagnostic tests have slowed the generation of clinical data which directly implicate the presence of M. genitalium in disease pathogenesis. In this study, we compared enzyme-linked immunosorbent assays (ELISAs) and immunoblot and PCR assays in M. genitalium culture-positive women over 1 to 3 years of clinical visits to determine the usefulness of independent diagnostic strategies. Furthermore, the value of combinatorial diagnostic assessments is described, which provides insights into the dynamics of M. genitalium-host interactions. Overall, we show that neither ELISA nor PCR, alone or in combination, provides the sensitivity required to confidently predict the existence of viable M. genitalium organisms in cervical and vaginal samples. Additionally, culture-positive women exhibited a range of antibody responsiveness to M. genitalium based upon ELISA and immunoblot assessments, indicating immune diversity among this high-risk population.
检测由生殖支原体介导的、衣原体阴性的非淋菌性尿道炎以及其他与生殖支原体相关的感染病因极具挑战性。尽管生殖支原体被认为是男性和女性泌尿生殖系统症状的主要病因之一,但由于其高度苛求的特性,培养极为困难,且缺乏常规有效的诊断测试,这减缓了直接表明生殖支原体在疾病发病机制中存在的临床数据的生成。在本研究中,我们在1至3年的临床访视期间,对生殖支原体培养阳性的女性进行了酶联免疫吸附测定(ELISA)、免疫印迹和PCR测定的比较,以确定独立诊断策略的实用性。此外,还描述了组合诊断评估的价值,这为生殖支原体与宿主相互作用的动态提供了见解。总体而言,我们表明,无论是单独的ELISA还是PCR,亦或是两者联合使用,都无法提供足够的敏感性来可靠地预测宫颈和阴道样本中活的生殖支原体的存在。此外,基于ELISA和免疫印迹评估,培养阳性的女性对生殖支原体表现出一系列抗体反应性,表明该高危人群中存在免疫多样性。